Skip Navigation



Rheumatology Advance Access published online on October 14, 2008

Rheumatology, doi:10.1093/rheumatology/ken388
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
48/2/119    most recent
ken388v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Martini, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martini, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Factors affecting survival in juvenile systemic sclerosis

G. Martini1, F. Vittadello1, Ö. Kasapçopur2, S. Magni Manzoni3, F. Corona4, C. Duarte-Salazar5, D. Nemcova6, C. A. Len7, S. M. Garay8, S. Ullman9, F. Zulian1 for the Juvenile Scleroderma Working Group of Paediatric Rheumatology European Society (PRES)

1Department of Paediatrics, University of Padua, Padova, Italy 2Department of Pediatrics, Cerrahpasa Tip Fakultesi, Istanbul, Turkey 3Department of Pediatrics, Fondazione IRCCS Policlinico S. Matteo, Pavia 4Clinica Pediatrica II De Marchi Milan, Milan, Italy 5Instituto Nacional de Rehabilitacion-Servicio de Reumatologia, Tlalpan, Mexico DF, Mexico 6First Faculty of Medicine and General Faculty Hospital, Praha, Czech Republic 7Department of Pediatrics, Universidade Federal de Sao Paulo, Sao Paulo, Brazil 8Unidad de Reumatologia Hospital Sor Maria Ludovica, La Plata, Argentina and 9University Hospitals, Copenhagen, Denmark.

Correspondence to: G. Martini, Department of Pediatrics, University of Padua, Via Giustiniani 3, 35128 Padua, Italy. E-mail: martini{at}pediatria.unipd.it


   Abstract

Objectives. To determine whether demographic, clinical and immunological features may predict the outcome in juvenile SSc (JSSc).

Methods. Clinical and laboratory characteristics of patients with JSSc collected from paediatric rheumatology centres worldwide were analysed. First, univariate tests identified those features significantly related with fatal outcome, and then multivariate logistic regression analysis was applied to determine the predictors of mortality.

Results. One hundred and thirty-four patients from 40 centres were eligible for the analysis. Sixteen patients died and a rapidly fatal course was observed in most of them: 4/16 died within 1 yr after diagnosis and 10/16 within 5 yrs. At the moment of diagnosis, patients with poor outcome showed a significantly higher frequency of internal organ involvement, particularly cardiac, respiratory and gastrointestinal systems. No significant difference emerged for entity of skin, vascular and musculo-skeletal involvement, nor for auto-antibodies profile and laboratory tests. Multivariate analysis showed the following factors to be significant predictors of mortality: fibrosis on chest X-rays [odds ratio (OR) 11.2], raised creatinine levels (OR 22.7) and pericarditis (OR 41.3), while a short disease duration at diagnosis conferred protection (OR 0.3).

Conclusions. All patients with JSSc and fatal outcome were affected by the diffuse form of the disease, and most of them showed a very rapid progression and early signs of internal organ involvement. This suggests that, in children, SSc may have two possible courses: a rapid development of internal organ failure leading to severe disability and eventually to death, or a slow course of the disease with lower mortality.

KEY WORDS: Scleroderma, Mortality, Systemic sclerosis, Child, Outcome

Submitted 23 November 2007; revised version accepted 5 September 2008.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
C. P. Denton and E. C. Derrett-Smith
Juvenile-onset systemic sclerosis: children are not small adults
Rheumatology, February 1, 2009; 48(2): 96 - 97.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.